transparency
SWEDEN – ENG
Transparency
EFPIA Disclosure Code Reports
AGB-Pharma discloses Transfers of Value to HCP’s and HCO’s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and/or local legal requirements, and in accordance with all applicable data protection laws and regulations.
AGB-Pharma is responsible for publishing Disclosure Reports for countries in Europe in which it operates, to strengthen the public trust in the relationships between pharmaceutical companies and HCPs and HCOs.
Please choose a country below to access the individual country reports.
Sweden
Documentation
Methodological Note (2022)
Sweden Transfer of Value Report (2022)
Methodological Note (2023)
Sweden Transfer of Value Report (2023)
Methodological Note (2024)
Sweden Transfer of Value Report (2024)
Denmark
Documentation
Methodological Note (2022)
Denmark Transfer of Value Report (2022)
Methodological Note (2023)
Denmark Transfer of Value Report (2023)
Methodological Note (2024)
Denmark Transfer of Value Report (2024)
Norway
Documentation
Methodological Note (2022)
Norway Transfer of Value Report 2022
Methodological Note (2023)
Norway Transfer of Value Report (2023)
No Transfers of Value have been made 2024
Personal Data Policy | Transparency | Cookie Policy | Contact
SE-MEL-AGB 0103 05/2025© 2024 AGB-Pharma AB. Last reviewed 05/2025
